 | • レポートコード：D005-11559 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、経口ロタウイルスワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。経口ロタウイルスワクチンの種類別市場規模（ロタリックス、ロタテック、ロタベック、ロタヴィン-M1、Lanzhouラム）、用途別市場規模（病院、予防接種ステーション、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：GSK、Biological E. Limited、Sanofi-Pasteur、Merck、Sinovac Biotech、China National Biotec Group ・地域別グローバル市場分析 2015年-2020年 ・経口ロタウイルスワクチンの北米市場（アメリカ、カナダ、メキシコ） ・経口ロタウイルスワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・経口ロタウイルスワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・経口ロタウイルスワクチンの南米市場（ブラジル、アルゼンチン） ・経口ロタウイルスワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ロタリックス、ロタテック、ロタベック、ロタヴィン-M1、Lanzhouラム ・用途別分析：病院、予防接種ステーション、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Oral Rotavirus Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Oral Rotavirus Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Oral Rotavirus Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Oral Rotavirus Vaccine market has been segmented into
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
By Application, Oral Rotavirus Vaccine has been segmented into:
Hospital
Vaccination Station
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Oral Rotavirus Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Oral Rotavirus Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oral Rotavirus Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Oral Rotavirus Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Oral Rotavirus Vaccine Market Share Analysis
Oral Rotavirus Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Oral Rotavirus Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oral Rotavirus Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Oral Rotavirus Vaccine are:
GSK
Biological E. Limited
Sanofi-Pasteur
Merck
Sinovac Biotech
China National Biotec Group
Among other players domestic and global, Oral Rotavirus Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Rotavirus Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral Rotavirus Vaccine, with price, sales, revenue and global market share of Oral Rotavirus Vaccine in 2018 and 2019.
Chapter 3, the Oral Rotavirus Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Rotavirus Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Oral Rotavirus Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Oral Rotavirus Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Oral Rotavirus Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oral Rotavirus Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Rotarix
1.2.3 RotaTeq
1.2.4 Rotavac
1.2.5 Rotavin-M1
1.2.6 Lanzhou lamb
1.3 Market Analysis by Application
1.3.1 Overview: Global Oral Rotavirus Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Vaccination Station
1.3.4 Other
1.4 Overview of Global Oral Rotavirus Vaccine Market
1.4.1 Global Oral Rotavirus Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GSK SWOT Analysis
2.1.4 GSK Product and Services
2.1.5 GSK Oral Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Biological E. Limited
2.2.1 Biological E. Limited Details
2.2.2 Biological E. Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Biological E. Limited SWOT Analysis
2.2.4 Biological E. Limited Product and Services
2.2.5 Biological E. Limited Oral Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi-Pasteur
2.3.1 Sanofi-Pasteur Details
2.3.2 Sanofi-Pasteur Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanofi-Pasteur SWOT Analysis
2.3.4 Sanofi-Pasteur Product and Services
2.3.5 Sanofi-Pasteur Oral Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Oral Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sinovac Biotech
2.5.1 Sinovac Biotech Details
2.5.2 Sinovac Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sinovac Biotech SWOT Analysis
2.5.4 Sinovac Biotech Product and Services
2.5.5 Sinovac Biotech Oral Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 China National Biotec Group
2.6.1 China National Biotec Group Details
2.6.2 China National Biotec Group Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 China National Biotec Group SWOT Analysis
2.6.4 China National Biotec Group Product and Services
2.6.5 China National Biotec Group Oral Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Oral Rotavirus Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Oral Rotavirus Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Oral Rotavirus Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Oral Rotavirus Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Oral Rotavirus Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Oral Rotavirus Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Oral Rotavirus Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Oral Rotavirus Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Oral Rotavirus Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Oral Rotavirus Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Oral Rotavirus Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Oral Rotavirus Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Oral Rotavirus Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
6.4 France Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Oral Rotavirus Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Oral Rotavirus Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Oral Rotavirus Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
7.5 India Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Oral Rotavirus Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Oral Rotavirus Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Oral Rotavirus Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Oral Rotavirus Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Oral Rotavirus Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Oral Rotavirus Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Oral Rotavirus Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Oral Rotavirus Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Oral Rotavirus Vaccine Price by Type (2015-2020)
11 Global Oral Rotavirus Vaccine Market Segment by Application
11.1 Global Oral Rotavirus Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Oral Rotavirus Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Oral Rotavirus Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Oral Rotavirus Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Oral Rotavirus Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Oral Rotavirus Vaccine Market Forecast (2021-2025)
12.2.2 Europe Oral Rotavirus Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Oral Rotavirus Vaccine Market Forecast (2021-2025)
12.2.4 South America Oral Rotavirus Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Oral Rotavirus Vaccine Market Forecast (2021-2025)
12.3 Oral Rotavirus Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Oral Rotavirus Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Oral Rotavirus Vaccine Market Share Forecast by Type (2021-2025)
12.4 Oral Rotavirus Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Oral Rotavirus Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Oral Rotavirus Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Oral Rotavirus Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Oral Rotavirus Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Oral Rotavirus Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Oral Rotavirus Vaccine Major Business
Table 9. GSK Oral Rotavirus Vaccine Total Revenue (USD Million) (2018-2019)
Table 10. GSK SWOT Analysis
Table 11. GSK Oral Rotavirus Vaccine Product and Services
Table 12. GSK Oral Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Biological E. Limited Basic Information, Manufacturing Base and Competitors
Table 14. Biological E. Limited Oral Rotavirus Vaccine Major Business
Table 15. Biological E. Limited Oral Rotavirus Vaccine Total Revenue (USD Million) (2018-2019)
Table 16. Biological E. Limited SWOT Analysis
Table 17. Biological E. Limited Oral Rotavirus Vaccine Product and Services
Table 18. Biological E. Limited Oral Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi-Pasteur Oral Rotavirus Vaccine Major Business
Table 21. Sanofi-Pasteur Oral Rotavirus Vaccine Total Revenue (USD Million) (2018-2019)
Table 22. Sanofi-Pasteur SWOT Analysis
Table 23. Sanofi-Pasteur Oral Rotavirus Vaccine Product and Services
Table 24. Sanofi-Pasteur Oral Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Merck Basic Information, Manufacturing Base and Competitors
Table 26. Merck Oral Rotavirus Vaccine Major Business
Table 27. Merck Oral Rotavirus Vaccine Total Revenue (USD Million) (2018-2019)
Table 28. Merck SWOT Analysis
Table 29. Merck Oral Rotavirus Vaccine Product and Services
Table 30. Merck Oral Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Sinovac Biotech Basic Information, Manufacturing Base and Competitors
Table 32. Sinovac Biotech Oral Rotavirus Vaccine Major Business
Table 33. Sinovac Biotech Oral Rotavirus Vaccine Total Revenue (USD Million) (2018-2019)
Table 34. Sinovac Biotech SWOT Analysis
Table 35. Sinovac Biotech Oral Rotavirus Vaccine Product and Services
Table 36. Sinovac Biotech Oral Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. China National Biotec Group Basic Information, Manufacturing Base and Competitors
Table 38. China National Biotec Group Oral Rotavirus Vaccine Major Business
Table 39. China National Biotec Group Oral Rotavirus Vaccine Total Revenue (USD Million) (2018-2019)
Table 40. China National Biotec Group SWOT Analysis
Table 41. China National Biotec Group Oral Rotavirus Vaccine Product and Services
Table 42. China National Biotec Group Oral Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Global Oral Rotavirus Vaccine Sales by Manufacturer (2018-2019) (K Pcs)
Table 44. Global Oral Rotavirus Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 45. Global Oral Rotavirus Vaccine Sales by Regions (2015-2020) (K Pcs)
Table 46. Global Oral Rotavirus Vaccine Sales Market Share by Regions (2015-2020)
Table 47. Global Oral Rotavirus Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 48. North America Oral Rotavirus Vaccine Sales by Countries (2015-2020) (K Pcs)
Table 49. North America Oral Rotavirus Vaccine Sales Market Share by Countries (2015-2020)
Table 50. North America Oral Rotavirus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 51. North America Oral Rotavirus Vaccine Revenue Market Share by Countries (2015-2020)
Table 52. Europe Oral Rotavirus Vaccine Sales by Countries (2015-2020) (K Pcs)
Table 53. Europe Oral Rotavirus Vaccine Sales Market Share by Countries (2015-2020)
Table 54. Europe Oral Rotavirus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 55. Asia-Pacific Oral Rotavirus Vaccine Sales by Regions (2015-2020) (K Pcs)
Table 56. Asia-Pacific Oral Rotavirus Vaccine Sales Market Share by Regions (2015-2020)
Table 57. Asia-Pacific Oral Rotavirus Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 58. South America Oral Rotavirus Vaccine Sales by Countries (2015-2020) (K Pcs)
Table 59. South America Oral Rotavirus Vaccine Sales Market Share by Countries (2015-2020)
Table 60. South America Oral Rotavirus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 61. South America Oral Rotavirus Vaccine Revenue Market Share by Countries (2015-2020)
Table 62. Middle East & Africa Oral Rotavirus Vaccine Sales by Countries (2015-2020) (K Pcs)
Table 63. Middle East & Africa Oral Rotavirus Vaccine Sales Market Share by Countries (2015-2020)
Table 64. Middle East & Africa Oral Rotavirus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 65. Middle East & Africa Oral Rotavirus Vaccine Revenue Market Share by Countries (2015-2020)
Table 66. Global Oral Rotavirus Vaccine Sales by Type (2015-2020) (K Pcs)
Table 67. Global Oral Rotavirus Vaccine Sales Share by Type (2015-2020)
Table 68. Global Oral Rotavirus Vaccine Revenue by Type (2015-2020) (USD Million)
Table 69. Global Oral Rotavirus Vaccine Revenue Share by Type (2015-2020)
Table 70. Global Oral Rotavirus Vaccine Sales by Application (2015-2020) (K Pcs)
Table 71. Global Oral Rotavirus Vaccine Sales Share by Application (2015-2020)
Table 72. Global Oral Rotavirus Vaccine Sales Forecast by Regions (2021-2025) (K Pcs)
Table 73. Global Oral Rotavirus Vaccine Market Share Forecast by Regions (2021-2025)
Table 74. Global Oral Rotavirus Vaccine Sales Forecast by Type (2021-2025) (K Pcs)
Table 75. Global Oral Rotavirus Vaccine Market Share Forecast by Type (2021-2025)
Table 76. Global Oral Rotavirus Vaccine Sales Forecast by Application (2021-2025)
Table 77. Global Oral Rotavirus Vaccine Market Share Forecast by Application (2021-2025)
Table 78. Direct Channel Pros & Cons
Table 79. Indirect Channel Pros & Cons
Table 80. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Oral Rotavirus Vaccine Picture
Figure 2. Global Sales Market Share of Oral Rotavirus Vaccine by Type in 2019
Figure 3. Rotarix Picture
Figure 4. RotaTeq Picture
Figure 5. Rotavac Picture
Figure 6. Rotavin-M1 Picture
Figure 7. Lanzhou lamb Picture
Figure 8. Oral Rotavirus Vaccine Sales Market Share by Application in 2018
Figure 9. Hospital Picture
Figure 10. Vaccination Station Picture
Figure 11. Other Picture
Figure 12. Global Oral Rotavirus Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Oral Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Oral Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Oral Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Oral Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Oral Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Oral Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Oral Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Oral Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Oral Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Oral Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Oral Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Oral Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Oral Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Oral Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Oral Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Oral Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Oral Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Oral Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Oral Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Oral Rotavirus Vaccine Sales Market Share by Manufacturer in 2019
Figure 33. Global Oral Rotavirus Vaccine Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Oral Rotavirus Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Oral Rotavirus Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Pcs)
Figure 38. Global Oral Rotavirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Oral Rotavirus Vaccine Revenue Market Share by Regions (2015-2020)
Figure 40. Global Oral Rotavirus Vaccine Revenue Market Share by Regions in 2018
Figure 41. North America Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
Figure 42. Europe Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
Figure 44. South America Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020)
Figure 46. North America Oral Rotavirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Oral Rotavirus Vaccine Sales Market Share by Countries (2015-2020)
Figure 48. North America Oral Rotavirus Vaccine Sales Market Share by Countries in 2018
Figure 49. North America Oral Rotavirus Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Oral Rotavirus Vaccine Revenue Market Share by Countries in 2018
Figure 51. United States Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Canada Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Mexico Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Europe Oral Rotavirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Oral Rotavirus Vaccine Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Oral Rotavirus Vaccine Revenue Market Share by Countries in 2019
Figure 57. Germany Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. UK Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. France Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Asia-Pacific Oral Rotavirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Oral Rotavirus Vaccine Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Oral Rotavirus Vaccine Revenue Market Share by Regions 2019
Figure 65. China Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Korea Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. India Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Southeast Asia Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. South America Oral Rotavirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Oral Rotavirus Vaccine Sales Market Share by Countries in 2019
Figure 72. South America Oral Rotavirus Vaccine Revenue Market Share by Countries in 2019
Figure 73. Brazil Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Argentina Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Middle East and Africa Oral Rotavirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Oral Rotavirus Vaccine Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Oral Rotavirus Vaccine Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Oral Rotavirus Vaccine Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Egypt Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Turkey Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. South Africa Oral Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Global Oral Rotavirus Vaccine Sales and Growth Rate (2021-2025) (K Pcs)
Figure 84. Global Oral Rotavirus Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Oral Rotavirus Vaccine Market Forecast (2021-2025) (K Pcs)
Figure 86. Europe Sales Oral Rotavirus Vaccine Market Forecast (2021-2025) (K Pcs)
Figure 87. Asia-Pacific Sales Oral Rotavirus Vaccine Market Forecast (2021-2025) (K Pcs)
Figure 88. South America Sales Oral Rotavirus Vaccine Market Forecast (2021-2025) (K Pcs)
Figure 89. Middle East & Africa Sales Oral Rotavirus Vaccine Market Forecast (2021-2025) (K Pcs)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
ジフテリア・百日咳・破傷風ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Diphtheria, Pertussis, and Tetanus Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.7% in the forecast period of 2020 to 2025 and will expected to reach USD 2999.7 million by 2025, from USD 2595 million in 2019.…- 麻疹ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Measle Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Measle Vaccine market report p…
- ライム病ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Lyme Disease Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Lyme Disease Vaccine mar…
- 肺炎球菌ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Pneumococcal Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.1% in the forecast period of 2020 to 2025 and will expected to reach USD 7551.8 million by 2025, from USD 7242 million in 2019. The Pneumococ…
- 日本脳炎ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Japanese Encephalitis (JE) Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Japanese E…